Ignite Creation Date:
2025-12-24 @ 5:37 PM
Ignite Modification Date:
2026-01-04 @ 4:09 PM
Study NCT ID:
NCT03503968
Status:
TERMINATED
Last Update Posted:
2023-02-15
First Post:
2018-03-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid Neoplasms
Sponsor:
Medigene AG
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-27
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-15
Completion Date Type:
ACTUAL
First Submit Date:
2018-03-21
First Submit QC Date:
None
Study First Post Date:
2018-04-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-13
Last Update Post Date:
2023-02-15
Last Update Post Date Type:
ACTUAL